These findings link previously reported robust clinical outcomes with underlying biochemical mechanisms, although the post-hoc exploratory analysis remains hypothesis-generating and does not prove causality
Nutritional Priorities to Support GLP-1 Therapy for Obesity. *American Journal of Clinical Nutrition*, 2025
Compounds such as Selank, Semax, and Cerebrolysin are investigated for their structural properties, receptor binding characteristics, and biochemical activity within controlled experimental models
This allows your provider to monitor whether your pain improves as weight loss progresses and blood sugar control deepens, potentially allowing future gabapentin dose reduction
Ozempic has not been studied specifically as a weight-loss medication
Your peptides are an investment in your health